Company RedHill Biopharma Ltd TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 02/08/09 |
Ori Shilo
FOU | Founder | 58 | 02/08/09 |
Razi Ingber
DFI | Director of Finance/CFO | - | 04/01/23 |
Gilead Raday
COO | Chief Operating Officer | 49 | 09/11/10 |
Ira N. Kalfus
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Reza Fathi
CTO | Chief Tech/Sci/R&D Officer | 69 | 30/04/10 |
kristin Comer
CMP | Compliance Officer | - | - |
June Almenoff
CTO | Chief Tech/Sci/R&D Officer | 67 | 27/05/19 |
Mark L. Levitt
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Terry F. Plasse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 31/12/15 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 25/08/10 |
Director/Board Member | 80 | 02/05/10 | |
Alla Felder
BRD | Director/Board Member | 50 | 05/05/19 |
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 02/08/09 |
Kenneth Reed
BRD | Director/Board Member | 70 | 14/12/09 |
Ofer Tsimchi
BRD | Director/Board Member | 64 | 03/05/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,869,853,000 | 7,791,154,470 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-4.26% | 86.85B | |
+2.76% | 40.16B | |
-16.48% | 31.28B | |
+57.86% | 25.27B | |
-13.58% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-10.53% | 7.94B |